Edwards Lifesciences to Present at the 32nd Annual J.P. Morgan Healthcare
IRVINE, CA -- (Marketwired) -- 01/09/14 -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, is scheduled to present at the
J.P. Morgan Healthcare Conference at the Westin St. Francis in San
Francisco on Monday, January 13, 2014.
Michael A. Mussallem, chairman and chief executive officer, is
scheduled to speak to conference attendees at 4:00 p.m. PT. A live
webcast of the presentation will be available to all interested
parties on the Edwards Lifesciences investor relations website at
http://ir.edwards.com/events.cfm. An archived version of the webcast
will be available later that day on the Edwards investor relations
website in the News and Events section and via the Edwards
Lifesciences Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader
in the science of heart valves and hemodynamic monitoring. Driven by
a passion to help patients, the company partners with clinicians to
develop innovative technologies in the areas of structural heart
disease and critical care monitoring that enable them to save and
enhance lives. Additional company information can be found at
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.
David K. Erickson
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Press spacebar to pause and continue. Press esc to stop.